Global β-Nicotinamide Mononucleotide (NMN) Market Growth 2021-2026

Report ID : 266147
Published On: Apr, 2021
Pages: 137
Chemicals and Materials

According to this latest study, the 2021 growth of β-Nicotinamide Mononucleotide (NMN) will have significant change from previous year. By the most conservative estimates of global β-Nicotinamide Mononucleotide (NMN) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the β-Nicotinamide Mononucleotide (NMN) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of β-Nicotinamide Mononucleotide (NMN) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Purity ＜98%

Purity ≥98%

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Health Care Products

Cosmetics

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

GeneHarbor

Herbalmax

Genex Formulas

Shinkowa Pharmaceutical

Maac10 Formulas

Bontac

Shandong Sihuan Pharmaceutical

EffePharm

Zhejiang Jiahua Pharmchemical

Frequently Asked Questions

What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

What are the significant segments operating in the market?

Market is segmented on the basis:

By Type
By Application
By Region
By Country
By Manufacturer

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global β-Nicotinamide Mononucleotide (NMN) Consumption 2016-2026

2.1.2 β-Nicotinamide Mononucleotide (NMN) Consumption CAGR by Region

2.2 β-Nicotinamide Mononucleotide (NMN) Segment by Type

2.2.1 Purity ＜98%

2.2.2 Purity ≥98%

2.3 β-Nicotinamide Mononucleotide (NMN) Sales by Type

2.3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2016-2021)

2.3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Type (2016-2021)

2.3.3 Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Type (2016-2021)

2.4 β-Nicotinamide Mononucleotide (NMN) Segment by Application

2.4.1 Health Care Products

2.4.2 Cosmetics

2.4.3 Others

2.5 β-Nicotinamide Mononucleotide (NMN) Sales by Application

2.5.1 Global β-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2016-2021)

2.5.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Application (2016-2021)

2.5.3 Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2016-2021)

3 Global β-Nicotinamide Mononucleotide (NMN) by Company

3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company

3.1.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Company (2019-2021)

3.1.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2019-2021)

3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company

3.2.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2021)

3.2.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2021)

3.3 Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Company

3.4 Global Manufacturers β-Nicotinamide Mononucleotide (NMN) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Product Location Distribution

3.4.2 Players β-Nicotinamide Mononucleotide (NMN) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 β-Nicotinamide Mononucleotide (NMN) by Region

4.1 Global β-Nicotinamide Mononucleotide (NMN) by Region

4.1.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region

4.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region

4.2 Americas β-Nicotinamide Mononucleotide (NMN) Sales Growth

4.3 APAC β-Nicotinamide Mononucleotide (NMN) Sales Growth

4.4 Europe β-Nicotinamide Mononucleotide (NMN) Sales Growth

4.5 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Growth

5 Americas

5.1 Americas β-Nicotinamide Mononucleotide (NMN) Sales by Country

5.1.1 Americas β-Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2021)

5.1.2 Americas β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2021)

5.2 Americas β-Nicotinamide Mononucleotide (NMN) Sales by Type

5.3 Americas β-Nicotinamide Mononucleotide (NMN) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC β-Nicotinamide Mononucleotide (NMN) Sales by Region

6.1.1 APAC β-Nicotinamide Mononucleotide (NMN) Sales by Region (2016-2021)

6.1.2 APAC β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2016-2021)

6.2 APAC β-Nicotinamide Mononucleotide (NMN) Sales by Type

6.3 APAC β-Nicotinamide Mononucleotide (NMN) Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe β-Nicotinamide Mononucleotide (NMN) by Country

7.1.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2021)

7.1.2 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2021)

7.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Type

7.3 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) by Country

8.1.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2021)

8.1.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2021)

8.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Type

8.3 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 β-Nicotinamide Mononucleotide (NMN) Distributors

10.3 β-Nicotinamide Mononucleotide (NMN) Customer

11 Global β-Nicotinamide Mononucleotide (NMN) Market Forecast

11.1 Global β-Nicotinamide Mononucleotide (NMN) Forecast by Region

11.1.1 Global β-Nicotinamide Mononucleotide (NMN) Forecast by Regions (2021-2026)

11.2.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global β-Nicotinamide Mononucleotide (NMN) Forecast by Type

11.7 Global β-Nicotinamide Mononucleotide (NMN) Forecast by Application

12 Key Players Analysis

12.1 GeneHarbor

12.1.1 GeneHarbor Company Information

12.1.2 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Offered

12.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 GeneHarbor Main Business Overview

12.1.5 GeneHarbor Latest Developments

12.2 Herbalmax

12.2.1 Herbalmax Company Information

12.2.2 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Offered

12.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Herbalmax Main Business Overview

12.2.5 Herbalmax Latest Developments

12.3 Genex Formulas

12.3.1 Genex Formulas Company Information

12.3.2 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Offered

12.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Genex Formulas Main Business Overview

12.3.5 Genex Formulas Latest Developments

12.4 Shinkowa Pharmaceutical

12.4.1 Shinkowa Pharmaceutical Company Information

12.4.2 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Offered

12.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Shinkowa Pharmaceutical Main Business Overview

12.4.5 Shinkowa Pharmaceutical Latest Developments

12.5 Maac10 Formulas

12.5.1 Maac10 Formulas Company Information

12.5.2 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Offered

12.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Maac10 Formulas Main Business Overview

12.5.5 Maac10 Formulas Latest Developments

12.6 Bontac

12.6.1 Bontac Company Information

12.6.2 Bontac β-Nicotinamide Mononucleotide (NMN) Product Offered

12.6.3 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Bontac Main Business Overview

12.6.5 Bontac Latest Developments

12.7 Shandong Sihuan Pharmaceutical

12.7.1 Shandong Sihuan Pharmaceutical Company Information

12.7.2 Shandong Sihuan Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Offered

12.7.3 Shandong Sihuan Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Shandong Sihuan Pharmaceutical Main Business Overview

12.7.5 Shandong Sihuan Pharmaceutical Latest Developments

12.8 EffePharm

12.8.1 EffePharm Company Information

12.8.2 EffePharm β-Nicotinamide Mononucleotide (NMN) Product Offered

12.8.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 EffePharm Main Business Overview

12.8.5 EffePharm Latest Developments

12.9 Zhejiang Jiahua Pharmchemical

12.9.1 Zhejiang Jiahua Pharmchemical Company Information

12.9.2 Zhejiang Jiahua Pharmchemical β-Nicotinamide Mononucleotide (NMN) Product Offered

12.9.3 Zhejiang Jiahua Pharmchemical β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Zhejiang Jiahua Pharmchemical Main Business Overview

12.9.5 Zhejiang Jiahua Pharmchemical Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Î²-Nicotinamide Mononucleotide (NMN) Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Purity ï¼œ98%

Table 3. Major Players of Purity â‰¥98%

Table 4. Global Î²-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2021) & (Kg)

Table 5. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2016-2021)

Table 6. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue by Type (2016-2021) & ($ million)

Table 7. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2016-2021)

Table 8. Global Î²-Nicotinamide Mononucleotide (NMN) Sale Price by Type (2016-2021)

Table 9. Global Î²-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2021) & (Kg)

Table 10. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2021)

Table 11. Global Î²-Nicotinamide Mononucleotide (NMN) Value by Application (2016-2021)

Table 12. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2016-2021)

Table 13. Global Î²-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2016-2021)

Table 14. Global Î²-Nicotinamide Mononucleotide (NMN) Sales by Company (2019-2021) & (Kg)

Table 15. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2019-2021)

Table 16. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2021)

Table 18. Global Î²-Nicotinamide Mononucleotide (NMN) Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Î²-Nicotinamide Mononucleotide (NMN) Producing Area Distribution and Sales Area

Table 20. Players Î²-Nicotinamide Mononucleotide (NMN) Products Offered

Table 21. Î²-Nicotinamide Mononucleotide (NMN) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Î²-Nicotinamide Mononucleotide (NMN) Sales by Region (2016-2021) (Kg)

Table 25. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2016-2021)

Table 26. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2016-2021)

Table 28. Americas Î²-Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2021) & (Kg)

Table 29. Americas Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2016-2021)

Table 30. Americas Î²-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2016-2021)

Table 32. Americas Î²-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2021) & (Kg)

Table 33. Americas Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2016-2021)

Table 34. Americas Î²-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2021) & (Kg)

Table 35. Americas Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2021)

Table 36. APAC Î²-Nicotinamide Mononucleotide (NMN) Sales by Region (2016-2021) & (Kg)

Table 37. APAC Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2016-2021)

Table 38. APAC Î²-Nicotinamide Mononucleotide (NMN) Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2016-2021)

Table 40. APAC Î²-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2021) & (Kg)

Table 41. APAC Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2016-2021)

Table 42. APAC Î²-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2021) & (Kg)

Table 43. APAC Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2021)

Table 44. Europe Î²-Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2021) & (Kg)

Table 45. Europe Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2016-2021)

Table 46. Europe Î²-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2016-2021)

Table 48. Europe Î²-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2021) & (Kg)

Table 49. Europe Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2016-2021)

Table 50. Europe Î²-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2021) & (Kg)

Table 51. Europe Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2021) & (Kg)

Table 53. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2021) & (Kg)

Table 57. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2021) & (Kg)

Table 59. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Î²-Nicotinamide Mononucleotide (NMN)

Table 61. Key Application and Potential Industries of Î²-Nicotinamide Mononucleotide (NMN)

Table 62. Key Challenges of Î²-Nicotinamide Mononucleotide (NMN)

Table 63. Key Trends of Î²-Nicotinamide Mononucleotide (NMN)

Table 64. Î²-Nicotinamide Mononucleotide (NMN) Distributors List

Table 65. Î²-Nicotinamide Mononucleotide (NMN) Customer List

Table 66. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2021-2026) & (Kg)

Table 67. Global Î²-Nicotinamide Mononucleotide (NMN) Consumption Market Forecast by Region

Table 68. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Î²-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2021-2026) & (Kg)

Table 71. Americas Î²-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Î²-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2021-2026) & (Kg)

Table 73. APAC Î²-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Î²-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2021-2026) & (Kg)

Table 75. Europe Î²-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2021-2026) & (Kg)

Table 77. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2021-2026) & (Kg)

Table 79. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2021-2026) & (Kg)

Table 83. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Application (2021-2026)

Table 86. GeneHarbor Basic Information, Î²-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors

Table 87. GeneHarbor Î²-Nicotinamide Mononucleotide (NMN) Product Offered

Table 88. GeneHarbor Î²-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 89. GeneHarbor Main Business

Table 90. GeneHarbor Latest Developments

Table 91. Herbalmax Basic Information, Î²-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors

Table 92. Herbalmax Î²-Nicotinamide Mononucleotide (NMN) Product Offered

Table 93. Herbalmax Î²-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 94. Herbalmax Main Business

Table 95. Herbalmax Latest Developments

Table 96. Genex Formulas Basic Information, Î²-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors

Table 97. Genex Formulas Î²-Nicotinamide Mononucleotide (NMN) Product Offered

Table 98. Genex Formulas Î²-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 99. Genex Formulas Main Business

Table 100. Genex Formulas Latest Developments

Table 101. Shinkowa Pharmaceutical Basic Information, Î²-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors

Table 102. Shinkowa Pharmaceutical Î²-Nicotinamide Mononucleotide (NMN) Product Offered

Table 103. Shinkowa Pharmaceutical Î²-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 104. Shinkowa Pharmaceutical Main Business

Table 105. Shinkowa Pharmaceutical Latest Developments

Table 106. Maac10 Formulas Basic Information, Î²-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors

Table 107. Maac10 Formulas Î²-Nicotinamide Mononucleotide (NMN) Product Offered

Table 108. Maac10 Formulas Î²-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 109. Maac10 Formulas Main Business

Table 110. Maac10 Formulas Latest Developments

Table 111. Bontac Basic Information, Î²-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors

Table 112. Bontac Î²-Nicotinamide Mononucleotide (NMN) Product Offered

Table 113. Bontac Î²-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 114. Bontac Main Business

Table 115. Bontac Latest Developments

Table 116. Shandong Sihuan Pharmaceutical Basic Information, Î²-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors

Table 117. Shandong Sihuan Pharmaceutical Î²-Nicotinamide Mononucleotide (NMN) Product Offered

Table 118. Shandong Sihuan Pharmaceutical Î²-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 119. Shandong Sihuan Pharmaceutical Main Business

Table 120. Shandong Sihuan Pharmaceutical Latest Developments

Table 121. EffePharm Basic Information, Î²-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors

Table 122. EffePharm Î²-Nicotinamide Mononucleotide (NMN) Product Offered

Table 123. EffePharm Î²-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 124. EffePharm Main Business

Table 125. EffePharm Latest Developments

Table 126. Zhejiang Jiahua Pharmchemical Basic Information, Î²-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors

Table 127. Zhejiang Jiahua Pharmchemical Î²-Nicotinamide Mononucleotide (NMN) Product Offered

Table 128. Zhejiang Jiahua Pharmchemical Î²-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)

Table 129. Zhejiang Jiahua Pharmchemical Main Business

Table 130. Zhejiang Jiahua Pharmchemical Latest Developments

List of Figures

Figure 1. Picture of Î²-Nicotinamide Mononucleotide (NMN)

Figure 2. Î²-Nicotinamide Mononucleotide (NMN) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Growth Rate 2016-2026 (Kg)

Figure 7. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Î²-Nicotinamide Mononucleotide (NMN) Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Purity ï¼œ98%

Figure 10. Product Picture of Purity â‰¥98%

Figure 11. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2020

Figure 12. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2016-2021)

Figure 13. Î²-Nicotinamide Mononucleotide (NMN) Consumed in Health Care Products

Figure 14. Global Î²-Nicotinamide Mononucleotide (NMN) Market: Health Care Products (2016-2021) & (Kg)

Figure 15. Î²-Nicotinamide Mononucleotide (NMN) Consumed in Cosmetics

Figure 16. Global Î²-Nicotinamide Mononucleotide (NMN) Market: Cosmetics (2016-2021) & (Kg)

Figure 17. Î²-Nicotinamide Mononucleotide (NMN) Consumed in Others

Figure 18. Global Î²-Nicotinamide Mononucleotide (NMN) Market: Others (2016-2021) & (Kg)

Figure 19. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2021)

Figure 20. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2020

Figure 21. Î²-Nicotinamide Mononucleotide (NMN) Revenue Market by Company in 2020 ($ Million)

Figure 22. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company in 2020

Figure 23. Global Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Regions (2016-2021)

Figure 24. Global Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region in 2020

Figure 25. Americas Î²-Nicotinamide Mononucleotide (NMN) Sales 2016-2021 (Kg)

Figure 26. Americas Î²-Nicotinamide Mononucleotide (NMN) Revenue 2016-2021 ($ Millions)

Figure 27. APAC Î²-Nicotinamide Mononucleotide (NMN) Sales 2016-2021 (Kg)

Figure 28. APAC Î²-Nicotinamide Mononucleotide (NMN) Revenue 2016-2021 ($ Millions)

Figure 29. Europe Î²-Nicotinamide Mononucleotide (NMN) Sales 2016-2021 (Kg)

Figure 30. Europe Î²-Nicotinamide Mononucleotide (NMN) Revenue 2016-2021 ($ Millions)

Figure 31. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Sales 2016-2021 (Kg)

Figure 32. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Revenue 2016-2021 ($ Millions)

Figure 33. Americas Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2020

Figure 34. Americas Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country in 2020

Figure 35. Americas Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2020

Figure 36. Americas Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application in 2020

Figure 37. United States Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 38. Canada Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 39. Mexico Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 40. Brazil Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 41. APAC Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2020

Figure 42. APAC Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Regions in 2020

Figure 43. APAC Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2020

Figure 44. APAC Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application in 2020

Figure 45. China Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 46. Japan Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 47. Korea Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 48. Southeast Asia Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 49. India Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 50. Australia Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 51. Europe Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2020

Figure 52. Europe Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country in 2020

Figure 53. Europe Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2020

Figure 54. Europe Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application in 2020

Figure 55. Germany Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 56. France Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 57. UK Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 58. Italy Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 59. Russia Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 60. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2020

Figure 61. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country in 2020

Figure 62. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2020

Figure 63. Middle East & Africa Î²-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application in 2020

Figure 64. Egypt Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 65. South Africa Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 66. Israel Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 67. Turkey Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 68. GCC Country Î²-Nicotinamide Mononucleotide (NMN) Revenue Growth 2016-2021 ($ Millions)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

Please fill the form below, to recieve the report sample

Full Name

Country

Phone

Company

Designation

Comment

Human Verification

Choose License Type

Reach Us

Q: What are the significant segments operating in the market?

Market is segmented on the basis. Read More

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery